We are live on ! Find out more
ICM

IMS Capital Management Portfolio holdings

AUM $217M
1-Year Est. Return 18.69%
This Fund
S&P 500
This Quarter Est. Return
+2.02%
1 Year Est. Return
+18.69%
3 Year Est. Return
+119.31%
5 Year Est. Return
+117.37%
10 Year Est. Return
+287.2%
AUM
$215M
AUM Growth
-$475K
Cap. Flow
+$4.55M
Cap. Flow %
2.12%
Top 10 Hldgs %
39.29%
Holding
151
New
9
Increased
50
Reduced
63
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 22.41%
2 Financials 12.03%
3 Industrials 11.94%
4 Consumer Discretionary 11.22%
5 Healthcare 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLY icon
151
Valley National Bancorp
VLY
$7.9B
-30,600
Closed -$244K

Similar funds

IMS Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, IMS Capital Management held 151 positions worth $215M, down 0.22% from $215M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

IMS Capital Management's Q2 2024 filing shows 9 new, 50 increased, 63 reduced and 10 closed positions. Its largest new stake was Canadian Pacific Kansas City: 6,710 shares worth $532K. The largest sale was JELD-WEN Holding, an estimated $1.6M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • IMS Capital Management's largest Q2 2024 buy was Canadian Pacific Kansas City: 6,710 shares worth $532K.
  • IMS Capital Management added most to Broadcom in Q2 2024, an estimated $8.47M increase.
  • IMS Capital Management's biggest Q2 2024 reduction was JELD-WEN Holding, cutting an estimated $1.6M.
  • IMS Capital Management fully exited CVS Health in Q2 2024, selling an estimated $490K.
  • IMS Capital Management's ten largest holdings make up 39% of its $215M portfolio in Q2 2024.
  • IMS Capital Management opened 9 new positions and closed 10 in Q2 2024.
  • IMS Capital Management's portfolio value fell 0.22% quarter-over-quarter to $215M.

Based on IMS Capital Management's 13F filing for Q2 2024, filed 21 Aug 2024.